newsfilter
← Latest News
PR Newswire·

Lilly to Acquire POINT Biopharma to Expand Oncology Capabilities into Next-Generation Radioligand Therapies

INDIANAPOLIS, Oct. 3, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) and POINT Biopharma Global, Inc. (NASDAQ:PNT) today announced a definitive agreement for Lilly to acquire POINT, a radiopharmaceutical company